HCI Frontiers Symposium: Signal Transduction & Pathway-Targeted Therapy

Friday, September 30, 2022
9 am - 6 pm
HCI Research South Auditorium

Register to Attend


Donita Brady, PhD
University of Pennsylvania
The role of copper in cancer cell signaling

Heather Christofk, PhD
University of California, Los Angeles
From signaling pathways to cancer cell metabolism

Piro Lito, MD, PhD
Memorial Sloan Kettering Cancer Center
Novel mechanisms of targeting RAS oncoproteins

Rushika Perera, PhD
University of California, San Francisco
Autophagy, lysosome function and cancer

Katie Politi, PhD
Yale University
Targeting mutationally activated EGFR in lung cancer


Poulikos Poulikakos, PhD
Icahn School of Medicine at Mount Sinai
Targeting signaling pathways for cancer therapy

Davide Ruggero, PhD
University of California, San Francisco
Novel mechanisms of action of the estrogen receptor

Charles Sawyers, MD
Memorial Sloan Kettering
Targeting cell signaling to inhibit the growth of chronic myeloid leukemia, prostate and other cancers

Mallika Singh, PhD
Revolution Medicines
Novel methods to target signaling pathways for cancer therapy

Alex Toker, PhD
Beth Israel Deaconess Medical Center
The role of PI3K>AKT signaling in cancer